Literature DB >> 19465121

Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.

P Srinarong1, J H Faber, M R Visser, W L J Hinrichs, H W Frijlink.   

Abstract

In this study, it was shown that the incorporation of superdisintegrants in solid dispersion tablets containing a high drug load can strongly enhance the dissolution rate of the highly lipophilic drug fenofibrate. In addition, the dissolution rate was more increased when the superdisintegrant was incorporated in the drug containing solid dispersions than when it was physically mixed with the solid dispersions. The dissolution rate enhancement strongly depended on the type of superdisintegrants and increased in the order Polyplasdone XL-10<Polyplasdone XL<<Ac-Di-Sol approximately Primojel. The dissolution behavior also depended on the type of hydrophilic carriers. Solid dispersion tablets based on inulin 4 kDa, polyethylene glycol 20K and polyvinylpyrrolidone K30 showed a much faster dissolution than those based on mannitol and hydroxypropyl-beta-cyclodextrin. Finally, inulin 4 kDa-based solid dispersion tablets showed excellent storage stability, while polyethylene glycol 20K-and polyvinylpyrrolidone K30-based solid dispersion tablets did not.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465121     DOI: 10.1016/j.ejpb.2009.05.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

1.  Impact of Superdisintegrants and Film Thickness on Disintegration Time of Strip Films Loaded With Poorly Water-Soluble Drug Microparticles.

Authors:  Lu Zhang; Marie Aloia; Barbara Pielecha-Safira; Honghao Lin; Prarthana Manoj Rajai; Kuriakose Kunnath; Rajesh N Davé
Journal:  J Pharm Sci       Date:  2018-04-14       Impact factor: 3.534

2.  Towards controlling the crystallisation behaviour of fenofibrate melt: triggers of crystallisation and polymorphic transformation.

Authors:  Pratchaya Tipduangta; Khaled Takieddin; László Fábián; Peter Belton; Sheng Qi
Journal:  RSC Adv       Date:  2018-04-10       Impact factor: 4.036

3.  In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.

Authors:  Yue Cao; Li-Li Shi; Qing-Ri Cao; Mingshi Yang; Jing-Hao Cui
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

4.  Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate.

Authors:  Moloud Kazemi; Jaleh Varshosaz; Majid Tabbakhian
Journal:  Adv Biomed Res       Date:  2018-09-21

5.  Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization.

Authors:  Abid Mehmood Yousaf; Usman Rashid Malik; Yasser Shahzad; Tariq Mahmood; Talib Hussain
Journal:  J Pharm Anal       Date:  2018-09-19

6.  Design Space Approach for the Optimization of Green Fluidized Bed Granulation Process in the Granulation of a Poorly Water-Soluble Fenofibrate Using Design of Experiment.

Authors:  Mohamed H Fayed; Ahmed Alalaiwe; Ziyad S Almalki; Doaa A Helal
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

7.  Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.

Authors:  Kwang-Ho Cha; Kyung-Jin Cho; Min-Soo Kim; Jeong-Soo Kim; Hee Jun Park; Junsung Park; Wonkyung Cho; Jeong-Sook Park; Sung-Joo Hwang
Journal:  Int J Nanomedicine       Date:  2012-10-25

8.  Enhancement of dissolution of Telmisartan through use of solid dispersion technique - surface solid dispersion.

Authors:  Bhumika Patel; R H Parikh; Deepali Swarnkar
Journal:  J Pharm Bioallied Sci       Date:  2012-03

9.  Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.

Authors:  Sultan Alshehri; Syed Sarim Imam; Afzal Hussain; Mohammad A Altamimi; Nabil K Alruwaili; Fahad Alotaibi; Abdullah Alanazi; Faiyaz Shakeel
Journal:  Drug Deliv       Date:  2020-11-09       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.